Echouffo-Tcheugui JB,Selvin E.,Prediabetes E. . .The Epidemiological Evidence. Annu Rev Public Health. 2021 Apr, 1(1) : 59-77.
Ciardullo S,Monti T,Perseghin G . .High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes. Diabetes Care. 2021 Feb, 1(2) : 519-25.
Lazarus J V.,Mark HE,Anstee QM,Arab JP,Batterham RL,Castera L . .Advancing the global public health agenda for NAFLD: a consensus statement. 2022 Jan, 27(1) : 60-78.
Song K,Park G,Lee HS,Lee M,Lee HI,Ahn J . .Trends in Prediabetes and Non-Alcoholic Fatty Liver Disease Associated with Abdominal Obesity among Korean Children and Adolescents: Based on the Korea National Health and Nutrition Examination Survey between 2009 and 2018. 2022 Mar, 2(3) : 584.
Song M,Zhao X,Shang Y. .2020 .The impact of low-carbon city construction on ecological efficiency: Empirical evidence from quasi-natural experiments. Resour Conserv Recycl, 157 : 104777.
Mendez-Sanchez N,Cruz-Ramon V,Ramirez-Perez O,Hwang J,Barranco-Fragoso B,Cordova-Gallardo J .2034 .New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. Int J Mol Sci. 2018 Jul, 13(7) : .
Apostolopoulou M,Gordillo R,Koliaki C,Gancheva S,Jelenik T,De Filippo E . .Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis. Diabetes Care. 2018 Jun, 1(6) : 1235-43.
Morgantini C,Jager J,Li X,Levi L,Azzimato V,Sulen A . .Liver macrophages regulate systemic metabolism through non-inflammatory factors. 2019 Mar, 25(4) : 445-59.
Coats BR,Schoenfelt KQ,Barbosa-Lorenzi VC,Peris E,Cui C,Hoffman A . .Metabolically Activated Adipose Tissue Macrophages Perform Detrimental and Beneficial Functions during Diet-Induced Obesity. Cell Rep, 20(13) : 3149-61.
Boutari C,Mantzoros CS . .Adiponectin and leptin in the diagnosis and therapy of NAFLD. , 103 : 154028.
Campo L,Eiseler S,Apfel T,Pyrsopoulos N. . .Fatty Liver Disease and Gut Microbiota: A Comprehensive Update. 2019 Mar, 28(1) : 1-5.
Hong S hyeon . .Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. Int J Mol Sci. 2020 Jan, 13(2) : 494.
Francque SM,Marchesini G,Kautz A,Walmsley M,Dorner R,Lazarus JV . .Non-alcoholic fatty liver disease: A patient guideline. JHEP Rep, 3(5) : 100322.
Ryan MC,Itsiopoulos C,Thodis T,Ward G,Trost N,Hofferberth S .2013 .The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol, 59(1) : 138-43.
WC Knowler SFRHCCHHAB .2009 .-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. The Lancet, 374(9702) : 1677-86.
Louheranta J,Mannelin A,Rastas M,Salminen M,Eriksson V,J V . .. Diabetes Care. 2003 Dec, 1(12) : 3230-6.
Srivastava RAK .2018 .Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity. J Diabetes Metab Disord, 17(2) : 381-91.
Li W,Zhu X,Song Y,Fan L,Wu L,Kabagambe EK .2018 .Intakes of magneisum, calcium and risk of fatty liver disease and prediabetes. Public Health Nutr, 21(11) : 2088-95.
Colletta C,Colletta A,Placentino G .2020 .Lifestyle and silymarin: A fight against liver damage in NAFLD associated - prediabetic disease. J Diabetes Metab Disord, 19(2) : 883-94.
ElSayed NA,Aleppo G,Aroda VR,Bannuru RR,Brown FM,Bruemmer D . .9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes2023. Diabetes Care. 2023 Jan, 1(Supplement) : S140-57.
Bhat A .2015 .Systematic review: Preventive and therapeutic applications of metformin in liver disease. World J Hepatol, 7(12) : 1652.
Cusi K,Orsak B,Bril F,Lomonaco R,Hecht J,OrtizLopez C . .Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus. 2016 Sep, 6(5) : 305.
Thondam SK,Cuthbertson DJ,Wilding JPH .2020 .The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD). Peptides (NY), 125 : 170208.
Mazidi M,Katsiki N,Mikhailidis DP,Banach M. . .Adiposity May Moderate the Link Between Choline Intake and Non-alcoholic Fatty Liver Disease. 2019 Oct, 3(7) : 633-9.
Bomhof MR,Parnell JA,Ramay HR,Crotty P,Rioux KP,Probert CS . .Histological improvement of nonalcoholic steatohepatitis with a prebiotic: a pilot clinical trial. 2019 Jun, 19(4) : 1735-45.
Kato H,Nagai Y,Ohta A,Tenjin A,Nakamura Y,Tsukiyama H .2015 .Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes. Diabetes Res Clin Pract, 109(1) : 199-205.
Cui J,Philo L,Nguyen P,Hofflich H,Hernandez C,Bettencourt R .2016 .Sitagliptin vs. placebo for nonalcoholic fatty liver disease: A randomized controlled trial. J Hepatol, 65(2) : 369-76.
Macauley M,Hollingsworth KG,Smith FE,Thelwall PE,Al-Mrabeh A,Schweizer A .2015 .. Effect of Vildagliptin on Hepatic Steatosis. J Clin Endocrinol Metab, 100(4) : 1578-85.
Hussain M,Majeed Babar MZ,Hussain MS,Akhtar L . .Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease. Pak J Med Sci. 2016 Nov, 15(6) : .
Mazzotti A,Caletti MT,Marchignoli F,Forlani G,Marchesini G.,Disease Liver .2017 .Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? Digestive. , 49(3) : 235-40.
Gunanti IR,Marks GC,Al-Mamun A,Long KZ .2014 .Low Serum Concentrations of Carotenoids and Vitamin E Are Associated with High Adiposity in Mexican-American Children. J Nutr, 144(4) : 489-95.
Khaire A,Rathod R,Kale A,Joshi S. Vitamin . .B12 and omega-3 fatty acids together regulate lipid metabolism in Wistar rats. Prostaglandins Leukot Essent Fatty Acids, 99 : 7-17.
Wang Y,Ausman LM,Greenberg AS,Russell RM,Wang XD . .Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitispromoted hepatocarcinogenesis in rats. 2010 Apr, 15(8) : 1788-96.